Movement Alert｜Agilent Intraday Rise 3.03% in Regular Trading, Evercore ISI Cuts Target Price to $172 While Digital Pathology Acquisition Supports Strategy

Market Focus10-28

On October 28, Agilent posted an Intraday Rise of 3.03% in Regular Trading, trading at $182.84 per share with turnover of $77.375 million.

The main disclosed catalyst was an analyst update: Evercore ISI lowered its target price on Agilent to $172 from $178, while the broader analyst consensus remained overweight with an average target price of $184.11.

Recent company developments provide additional context. Earlier in October, Agilent agreed to acquire digital pathology software company Proscia for $240 million in cash, with up to $30 million in contingent payments. The deal is expected to close early in fiscal 2027 and is intended to expand Agilent's digital pathology and AI-enabled precision medicine capabilities while adding recurring software revenue.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment